Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

Marie Skłodowska-Curie Action · Running

SOUND Stimulation Obtained by Ultrasound for NeuroDegeneration (SOUND)

Coordinator
Fondazione Istituto Italiano Di Tecnologia, Italy
Runs
1 October 2023 to 30 June 2026
Status
Running
EU funding
€175k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101108198

What the project is doing

In the project's own words, from its summary on CORDIS.

Neurodegeneration (ND) is a pathological process characterized by a progressive loss of structure and activity in neurons of specific brain areas, causing cognitive, sensory, and motor impairment until compromising even basic actions such as breathing and heart functioning. The condition affects over 100 million people globally, and it is estimated that ND incidence will constantly increase in the next decades, because of the increasing ageing of the European population and environmental factors.

Nevertheless, the current treatments are not satisfactory, either because they become ineffective over time, e.g., pharmacological treatment, or because they are highly invasive, i.e. for deep brain stimulation or optogenetic approaches. In this landscape, nanotechnology is emerging as an innovative alternative for treating ND. Nanomaterials offer unique features that confer them the chance to activate degenerated neurons, therefore rescuing the network activity lost in ND.

Here, we propose the preparation of a wireless, non-invasive, deep tissue penetrating nanotechnological platform for neuronal rescue upon ultrasound stimulation. We aim to develop a hybrid nanotool based on visible light-sensitive photovoltaic polymeric nanoparticles (that proved successful in rescuing several degenerated retina models in vivo) that will be conjugated to an ultrasound sensitizer, consisting of sonoluminescent molecules capable of transducing an ultrasound signal into a fluorescent emission that can excite the polymeric nanoparticles, ultimately eliciting a neuronal response.

The construct will then be directed towards a specific neural population through a targeting moiety, consisting of an M13 bacteriophage nanoscaffold naturally possessing high targeting efficiency. The final nanotool will be tested in different 2D and 3D in vitro models to assess its biocompatibility, brain blood barrier permeability and neural rescuing efficiency.

Topics

Who is involved

OrganisationCityCountryRole
Fondazione Istituto Italiano Di TecnologiaGenovaItalyCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI